【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Drug Delivery Infusion Systems Overview 12
3 Products under Development 14
3.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 14
3.2 Drug Delivery Infusion Systems – Pipeline Products by Segment 15
3.3 Drug Delivery Infusion Systems – Pipeline Products by Territory 16
3.4 Drug Delivery Infusion Systems – Pipeline Products by Regulatory Path 17
3.5 Drug Delivery Infusion Systems – Pipeline Products by Estimated Approval Date 18
3.6 Drug Delivery Infusion Systems – Ongoing Clinical Trials 19
4 Drug Delivery Infusion Systems – Pipeline Products under Development by Companies 20
4.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 20
4.2 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 22
5 Drug Delivery Infusion Systems Companies and Product Overview 24
5.1 410 Medical Innovation, LLC Company Overview 24
5.1.1 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Acuros GmbH Company Overview 25
5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AktiVax Inc. Company Overview 26
5.3.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Alnylam Pharmaceuticals, Inc. Company Overview 27
5.4.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Anesthesia Safety Products, LLC Company Overview 29
5.5.1 Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 AngioDynamics, Inc. Company Overview 30
5.6.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Automedics Medical Systems Company Overview 34
5.7.1 Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Baxter International Inc. Company Overview 35
5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 BioCardia, Inc. Company Overview 36
5.9.1 BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Debiotech S.A. Company Overview 38
5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Delpor, Inc. Company Overview 40
5.11.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Edwards Lifesciences Corporation Company Overview 42
5.12.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 Eksigent Technologies, LLC Company Overview 43
5.13.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 Eli Lilly and Company Company Overview 45
5.14.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Flowonix Medical, Inc. Company Overview 47
5.15.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 FluidSynchrony, LLC Company Overview 48
5.16.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Fluonic, Inc. Company Overview 49
5.17.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Fresenius Kidney Care Company Overview 50
5.18.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Imagnus Biomedical Inc. Company Overview 51
5.19.1 Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Innovfusion Pte. Ltd. Company Overview 52
5.20.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Intarcia Therapeutics, Inc. Company Overview 55
5.21.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 IRadimed Corporation Company Overview 59
5.22.1 IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 Ivenix, Inc. Company Overview 61
5.23.1 Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.24 LifeMedix, LLC Company Overview 63
5.24.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.25 Lynntech, Inc. Company Overview 64
5.25.1 Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 Medallion Therapeutics, Inc. Company Overview 65
5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Medical Device Creations Ltd. Company Overview 66
5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.28 MedPrime Technologies Pvt. Ltd. Company Overview 67
5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.29 Mercator MedSystems, Inc. Company Overview 68
5.29.1 Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Nano Precision Medical Company Overview 72
5.30.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 NexGen Medical Systems, Inc. Company Overview 73
5.31.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 Nipro Corporation Company Overview 74
5.32.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Owen Mumford Limited Company Overview 76
5.33.1 Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Pavmed Inc Company Overview 77
5.34.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.35 PRO-IV Medical Ltd. Company Overview 78
5.35.1 PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
5.36 Ratio, Inc. Company Overview 81
5.36.1 Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.37 Rice University Company Overview 82
5.37.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 82
5.38 SteadyMed Therapeutics, Inc. Company Overview 83
5.38.1 SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.39 StnDrd Infusion Corporation Company Overview 85
5.39.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.40 Tel Aviv University Company Overview 87
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87
5.41 Terumo Corporation Company Overview 88
5.41.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.42 ToucheMedical Ltd. Company Overview 90
5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90
5.43 Unilife Corporation Company Overview 91
5.43.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91
5.44 University of Minnesota Company Overview 93
5.44.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93
5.45 University of Southern California Company Overview 95
5.45.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
6 Drug Delivery Infusion Systems – Recent Developments 96
6.1 Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation 96
6.2 Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board 96
6.3 Jun 13, 2016: Aarti Shah named chief information officer 97
6.4 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 97
6.5 Jun 09, 2016: IRADIMED Provides Regulatory Update 99
6.6 Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases 100
6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100
6.8 Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender 101
6.9 Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner 101
6.10 Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing 102
6.11 Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing 102
6.12 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 102
6.13 May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results 104
6.14 May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 105
6.15 May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months 106
6.16 May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 107
6.17 May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments 107
6.18 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 108
6.19 May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors 109
6.20 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 110
6.21 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 110
6.22 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 111
6.23 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 111
6.24 May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results 111
6.25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 112
6.26 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 113
6.27 May 06, 2016: Alimera Sciences’ ILUVIEN Data Presented At 2016 ARVO 114
6.28 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 115
6.29 May 03, 2016: Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016 116
6.30 Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results 118
6.31 Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID 119
6.32 Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 120
6.33 Apr 01, 2016: IRADIMED Provides Regulatory Update 120
6.34 Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded 120
6.35 Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA 121
6.36 Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter 121
6.37 Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC 121
6.38 Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC 122
6.39 Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps 122
6.40 Feb 24, 2016: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets 123
6.41 Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract 127
6.42 Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 128
6.43 Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results 128
6.44 Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial 129
6.45 Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting 130
6.46 Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira 130
6.47 Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance 131
6.48 Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer 131
6.49 Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission 132
6.50 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing 132
6.51 Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing 132
6.52 Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares 133
6.53 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 133
6.54 Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results 133
6.55 Oct 30, 2015: IRADIMED Announces Dismissal of Appeal 134
6.56 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 134
6.57 Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion 135
6.58 Oct 08, 2015: Smiths Medical Awarded Contract by Novation 135
6.59 Oct 08, 2015: Bespak Launches New Brand Identity To The Market 136
6.60 Oct 05, 2015: Medicom receives the growth award – Borsen Gazelle 2015 136
6.61 Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System 136
6.62 Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump 137
6.63 Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation’s BioInterface 2015 Annual Symposium 138
6.64 Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device 138
6.65 Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet 138
6.66 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 139
6.67 Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication – Cybersecurity Vulnerabilities 140
6.68 Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results 140
6.69 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 141
6.70 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 142
6.71 Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders 143
6.72 Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice 144
7 Appendix 145
7.1 Methodology 145
7.2 About GlobalData 147
7.3 Contact Us 148
7.4 Disclaimer 148
【レポート販売概要】
■ タイトル：世界の薬物送達注入装置市場：医療機器パイプライン分析2016■ 英文：Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
■ 発行日：2016年7月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0209EPD
■ 調査対象地域：グローバル
- Oil India Limited社の石油・ガス開発・生産動向及びコスト分析（2013年）Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- 水陸両用・上陸用舟艇の世界市場：LCAC（ホバークラフト型の揚陸舟艇）、LCM（中型の揚陸舟艇）、LCU（大型の揚陸舟艇）About Amphibious Landing Crafts Landing crafts are boats or crafts used to transport troops, equipment, and military vehicles from sea to shore during amphibious assault. Amphibious operations are a feature of modern day warfare. Modern day landing crafts were first developed in the US and are segmented into three categories based on product type: LCAC, LCM, and LCU. Changing customer requirements …
- アルツハイマー型認知症治療薬の世界市場予測および分析PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. During the early stages of disease, sleep disturbances and forgetfulness are generally the first presenting symptoms. In the severe stages, patients with AD …
- ロシアの石炭産業分析：Analyzing the Coal Industry in RussiaThe erstwhile Soviet Union which covered 1/8th of the entire world’s land mass had been a storehouse of Global Energy Sources in magnum quantities far beyond the capacity potentials of many Asian countries put together. Most of the high coal production basins of Russia had already been explored before the break up of the country into independent entities. The same is indicative of the fragmentatio …
- 植物育成ライトの世界市場予測（～2022）The grow lights market is expected to grow at a CAGR of 11.86 % between 2017 and 2022 to be valued at USD 5.11 Billion by 2022. Grow lights, especially LEDs are used in a wide range of farming-related applications, owing to the advantages they offer such as high reliability, low power consumption, and spectral intensity. The increasing commercial greenhouse and vertical farming practices, which re …
- データ・ファブリックの世界市場予測（～2022年）：ディスクデータファブリック、インメモリデータファブリックThe data fabric market size is expected to grow from USD 653.5 Million in 2017 to USD 2,125.1 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 26.6% during the forecast period. The major growth drivers of the market include increasing volume and variety of business data, emerging need for business agility and accessibility, and growing demand for real-time streaming analytics. The data …
- 腎細胞癌の疫学的予測EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. RCC is the most common type of kidney cancer in adults, being responsible for approximately 90% of …
- 世界のガス絶縁型スイッチギヤ（開閉装置）市場動向（2014-2018）TechNavio’s analysts forecast the Global Gas Insulated Switchgear market will grow at a CAGR of 10.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing urbanization and space constraints in metropolitan cities. The Global Gas Insulated Switchgear market has also been witnessing an increasing focus on developing smaller and more efficient …
- 防汚塗料の世界市場分析：用途別（輸送船、掘削リグ･生産プラットフォーム）、セグメント予測 – 2022The global Antifouling Coating Market is expected to reach USD 2.43 billion by 2022, according to a new report by Grand View Research, Inc. Antifouling coatings are applied in order to increase the durability of hulls and underwater surfaces of marine vessels including passenger ships, cargoes, yachts and drilling rigs. Increasing number of merchant fleets on account of improvement of ship-based l …
- フィールドサービスマネジメント（FSM）の世界市場予測（～2024年）Growing demand for mobility-based solutions to improve field service operations and maximizing the productivity of field service technicians with the help of advanced technology are expected to drive the growth of the field service management market The global field service management market size is expected to grow from USD 2.8 billion in 2019 to USD 5.9 billion by 2024, at a CAGR of 16.2% during …
- 世界の低侵襲医療機器市場動向：低侵襲手術デバイス、低侵襲内視鏡、低侵襲可視化・モニタリングデバイスThe Healthcare industry has witnessed several technological advancements in the fields of diagnostics, wound care, resections, and medical equipments, among others. In line with the demand of value-based medicine, healthcare community is determined to equip the medical sector with next generation surgery procedures known as ‘Minimally Invasive Surgeries’. With the minimally invasive technology, su …
- バイタルサインモニタリング装置の世界市場：体温、血圧、パルスオキシメーターAbout Vital Signs Monitoring Devices Vital sign monitors are used to measure body temperature, heart rate, respiration rate, and blood pressure. Vital signs can be measured, monitored, and observed with the use of several diagnostic devices. These devices have applications in both fitness monitoring and medical diagnostics. It also provides information related to abnormalities of a patient to medi …
- 腎瘻造設用デバイスの世界市場2019-2023About this market The rising incidence of kidney stone disease will drive the nephrostomy devices market in the forthcoming years. Kidney stones are allied with an increased risk of chronic kidney disease, end-stage renal failure, diabetes, hypertension, and cardiovascular diseases. These kidney stones also affect the kidney function, in turn, obstructing ureter while blocking the urine flow. As a …
- 世界の酪農食品市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global dairy food market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global dairy food market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global d …
- 酸化コバルト・ナノ粒子の世界市場2010-2025This 11 page report from Future Markets, Inc. provides a comprehensive and succinct insight into the cobalt oxide nanoparticles market. Cobalt oxide nanoparticles (CoO-NPs) are promising materials for application in magnetics fluids, catalysts and electronic storage. CoO-NPs have a wide range of exceptional structural, electrical, magnetics and catalytic properties. Due to their large surface area …
